BiotechTube
Home/Contineum Therapeutics/Matthew (Matt) St. Clair
M(

Matthew (Matt) St. Clair

Chief Business Officer

Contineum Therapeutics

Therapeutic Areas

NeuroscienceInflammationImmunology

Contineum Therapeutics Pipeline

DrugIndicationPhase
PIPE-307Relapsing Remitting Multiple Sclerosis (RRMS)Phase 2
PIPE-791Idiopathic Pulmonary Fibrosis (IPF)Phase 1

Leadership Team at Contineum Therapeutics

DC
Dr. Carmine Stengone
President and Chief Executive Officer
DM
Dr. Mark McDonnell
Chief Scientific Officer
DW
Dr. William (Bill) H. Rote
Senior Vice President, Head of Research
DJ
Dr. John C. R. Randall
Chief Development Officer
VL
Vickie L. Reed
Chief Financial Officer
DD
Dr. David L. Lacey
Chairman of the Board
DD
Dr. Douglas E. Williams
Board Member
DE
Dr. Eliseo Salinas
Board Member
K(
Katherine (Kate) Dawson
Board Member
DM
Dr. Mark I. Greene
Board Member
View full Contineum Therapeutics profile